Exelixis Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Exelixis Inc (EXEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 851.13 thousand shares for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-06.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2013-08-06
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-06-30 was 566.52K shares, a 271.55% increase year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-03-31 was 284.61K shares, a 330.09% increase year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-09-30 was 3.08M shares.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-06-30 was 152.47K shares.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2011 was 2.55M shares, a 945.43% increase from fiscal 2010.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2010 was 243.50K shares, a 98.00% decline from fiscal 2009.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2009 was 12.18M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2013-06-30 | 566.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 851.13K shares 10-Q · filed 2013-08-06 | ||
| 2013-03-31 | 284.61K shares 10-Q · filed 2013-05-07 | |||
| 2012-09-30 | 3.08M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 3.23M shares derived: sum of 2 quarters · filed 2012-11-07 | 3.30M shares 10-Q · filed 2012-11-07 | |
| 2012-06-30 | 152.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | 218.65K shares 10-Q · filed 2012-08-02 | ||
| 2012-03-31 | 66.17K shares 10-Q · filed 2012-05-03 | |||
| 2011-12-31 | 2.55M shares 10-K · filed 2012-02-22 | |||
| 2010-12-31 | 243.50K shares 10-K · filed 2012-02-22 | |||
| 2009-12-31 | 12.18M shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |